CytoMed Therapeutics Limited (GDTC)
GDTC Stock Price Chart
Explore CytoMed Therapeutics Limited interactive price chart. Choose custom timeframes to analyze GDTC price movements and trends.
GDTC Company Profile
Discover essential business fundamentals and corporate details for CytoMed Therapeutics Limited (GDTC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
14 Apr 2023
Employees
43.00
Website
https://w2.cytomed.sgCEO
Chee Kong Choo
Description
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company's lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, which utilizes iPSC as a starting material to generate gdNKT, a synthetic hybrid of a gamma delta T cell and a NK cell; and CTM-GDT, a product candidate that consists of expanded gamma delta T cells, and exploits the multiple recognition system of gamma delta T cell to recognize and treat a range of cancers. The company was incorporated in 2018 and is headquartered in Singapore.
GDTC Financial Timeline
Browse a chronological timeline of CytoMed Therapeutics Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 28 Apr 2025
EPS came in at -$0.07 , while revenue for the quarter reached $38.37K .
Earnings released on 30 Sept 2024
EPS came in at -$0.07 .
Earnings released on 30 Jun 2024
EPS came in at -$0.05 .
Earnings released on 6 May 2024
EPS came in at -$0.03 , while revenue for the quarter reached $61.42K .
Earnings released on 22 Apr 2024
EPS came in at -$0.05 , while revenue for the quarter reached $63.95K .
Earnings released on 30 Sept 2023
EPS came in at -$0.05 , while revenue for the quarter reached $59.70K .
Earnings released on 30 Jun 2023
EPS came in at -$0.10 , while revenue for the quarter reached $77.64K .
Earnings released on 1 May 2023
EPS came in at -$0.10 , while revenue for the quarter reached $80.24K .
Earnings released on 31 Mar 2023
EPS came in at -$0.06 , while revenue for the quarter reached $80.34K .
Earnings released on 30 Sept 2022
EPS came in at -$0.06 , while revenue for the quarter reached $70.23K .
Earnings released on 30 Jun 2022
EPS came in at -$0.00 .
Earnings released on 31 Mar 2022
EPS came in at -$0.04 , while revenue for the quarter reached $20.28K .
Earnings released on 31 Dec 2021
EPS came in at -$0.04 , while revenue for the quarter reached $62.24K .
Earnings released on 30 Sept 2021
EPS came in at -$0.04 , while revenue for the quarter reached $23.09K .
Earnings released on 30 Jun 2021
EPS came in at -$0.00 .
Earnings released on 31 Mar 2021
EPS came in at -$0.04 , while revenue for the quarter reached $7.91K .
Earnings released on 31 Dec 2020
EPS came in at -$0.07 , while revenue for the quarter reached $17.01K .
Earnings released on 30 Sept 2020
EPS came in at -$0.06 , while revenue for the quarter reached $15.96K .
GDTC Stock Performance
Access detailed GDTC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.